Kirk Taylor Announces Postdoctoral Research Opportunity on Megakaryocyte and Platelet Communication at University of Reading
Kirk Taylor, Lecturer in Biomedical Sciences in the University of Reading, shared an insightful post on LinkedIn:
“Pleased to share that we are looking to recruit a postdoc to join the Reading Platelet Group.
This is an exciting project that will explore how megakaryocytes and platelets communicate using advanced microscopy and flow cytometry approaches.
The project will dissect and characterise intercellular communication pathways to build a model of how megakaryocytes and platelets interact. The experimental design will increase the complexity of interactions and the role of control mechanisms in 2D, 3D, and 4D. Using established in vivo approaches, the post holder will design and conduct assays to model thrombus formation under physiologically relevant conditions.
The postholder is expected to be a central link in the communication of staff involved in the project. In particular, this includes collaboration with a second PDRA employed by the project responsible for theoretical and computational developments. Strong communication skills and an ability to work in a multidisciplinary environment are hence essential.”
Apply here:
Stay updated with Hemostasis Today.
-
Mar 20, 2026, 16:23Eva Soler Espejo։ Atherogenic Index of Plasma and Residual Risk in Atrial Fibrillation
-
Mar 20, 2026, 16:22Welcoming Samer Al Hadidi to the Blood Cancers Team – UT Southwestern Simmons Cancer Center
-
Mar 20, 2026, 16:21Maxime Dely: The Lifesaving Power of Plasma Donations
-
Mar 20, 2026, 16:20Yves Bikorimana: Hemolysis – Why It Ruins Laboratory Results
-
Mar 20, 2026, 16:19Simon Senanu: G6PD Deficiency Testing – What the Lab Must Get Right
-
Mar 20, 2026, 16:18Khaled Elshazly: Can We Stop Chemotherapy-Induced Thrombocytopenia from Delaying Treatment?
-
Mar 20, 2026, 15:50Rithwic Mani: Platelet-to-Lymphocyte Ratio as A Simple and Cost-Effective Prognostic Biomarker in Stroke
-
Mar 20, 2026, 15:46Umberto Pensato: Presenting ESCAPE-MeVO Trial’s Practice-Changing Results at ESOC 2026
-
Mar 20, 2026, 15:42Varun Bafna: The Power of Extended Half-Life Factor IX in Enabling Safe Major Surgeries